Diversified Healthcare Trust cash flow to debt ratio of -0.81% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Diversified Healthcare Trust's free cash flow has decreased 117.48% from $112.22M last year to $-19.62M, signaling decreasing performance

Diversified Healthcare Trust's debt to equity ratio is 1.53, which means that the company's assets are unhealthy financed, signaling financial risk.

Diversified Healthcare Trust's debt has increased relative to shareholder equity from 1.49 last year to 1.53 today, signaling weakened financials

Diversified Healthcare Trust has a net debt to EBITDA ratio of 12.60x, which exceeds the 3.00x threshold, indicating high leverage and potential financial risk

Diversified Healthcare Trust's interest coverage ratio is -0.14, which means that the company struggles to meet interest obligations, signaling financial risk.

Diversified Healthcare Trust's profit margin has increased (-28.40%) in the last year from -24.76% to -17.73%, signaling increasing performance

Diversified Healthcare Trust's short-term assets of $187.93M exceed its short-term liabilities of $1.87M

Diversified Healthcare Trust's return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Diversified Healthcare Trust's return on equity of -16.22%, is lower than 15.00%, indicating bad performance

Diversified Healthcare Trust's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Diversified Healthcare Trust had positive net income in only 1 out of 5 years, indicating unstable earnings

Diversified Healthcare Trust has negative free cash flow, indicating the company is burning cash rather than generating it

Diversified Healthcare Trust has negative free cash flow, indicating cash burn

Diversified Healthcare Trust's yearly earnings has increased -22.79% since last year from $-370.25M to $-285.89M, signaling increasing performance

Diversified Healthcare Trust's yearly revenue has increased 2.84% since last year from $1.50B to $1.54B, signaling increasing performance

ROIC -23.04% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Diversified Healthcare Trust's 3-year revenue CAGR of 6.21% is positive, indicating growing revenue over the past 3 years

Diversified Healthcare Trust had revenue growth in 3 out of 5 years, indicating consistent revenue performance

Diversified Healthcare Trust had positive ROE in only 1 out of 5 years, indicating inconsistent returns on equity

Diversified Healthcare Trust has insufficient data to evaluate this check.

Diversified Healthcare Trust has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Diversified Healthcare Trust is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Diversified Healthcare Trust has an EV/EBITDA ratio of 23.77x, which exceeds the 20.00x threshold, indicating the stock may be overvalued relative to its operating earnings

Diversified Healthcare Trust is overvalued relative to its fair value price of -0.43 based on Earnings Fair Value model

Diversified Healthcare Trust has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Diversified Healthcare Trust has a price-to-book ratio of 1.28x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Diversified Healthcare Trust has a price-to-sales ratio of 1.35x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue